MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 08-08-2025
Country |
 USA |
IPO year |
1998 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
Shares |
14.2 M |
Market Cap[1] |
$ 608 M |
EBITDA (LTM) |
$ -8.65 M |
P/E (LTM) |
- |
P/S (LTM) |
5.16 |
EPS (LTM) |
-1.52 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Brainsway Ltd.
BWAY
|
$ 13.65 | -0.44 % | $ 99.4 M | Nasdaq Global Select Market |  Israel |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Bioventus
BVS
|
$ 8.87 | 2.9 % | $ 591 M | Nasdaq Global Select Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Charles River Laboratories International
CRL
|
$ 151.97 | -2.34 % | $ 7.53 B | NYSE,SPB | USA |
 |
Castle Biosciences
CSTL
|
$ 25.83 | 1.06 % | $ 717 M | Nasdaq Global Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 17.32 | 1.82 % | $ 923 M | Nasdaq Global Market,SPB | USA |
 |
DexCom
DXCM
|
$ 66.34 | 3.27 % | $ 25.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Exact Sciences Corporation
EXAS
|
$ 103.85 | 0.27 % | $ 19.6 B | Nasdaq Capital Market,SPB | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Fulgent Genetics
FLGT
|
$ 14.95 | 1.22 % | $ 452 M | Nasdaq Global Market | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
|
Biodesix
BDSX
|
$ 17.29 | -3.3 % | $ 2.24 B | Nasdaq Global Market | USA |
 |
Guardant Health
GH
|
$ 87.18 | 1.98 % | $ 10.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Anixa Biosciences
ANIX
|
$ 2.84 | 0.35 % | $ 92.2 K | Nasdaq Capital Market | USA |
 |
Danaher Corporation
DHR
|
$ 191.39 | 2.17 % | $ 136 B | NYSE,SPB | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 97.61 | -0.73 % | $ 8.05 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
IQVIA Holdings
IQV
|
$ 164.89 | 0.1 % | $ 28.3 B | NYSE,SPB | USA |
 |
Illumina
ILMN
|
$ 119.28 | 0.29 % | $ 19 B | Nasdaq Global Select Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 198.94 | -0.38 % | $ 22.1 B | NYSE,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Agilent Technologies
A
|
$ 111.83 | 0.28 % | $ 34 B | NYSE,SPB | USA |
 |
BioNano Genomics
BNGO
|
$ 1.11 | - | $ 1.41 M | Nasdaq Capital Market,SPB | USA |
 |
DarioHealth Corp.
DRIO
|
$ 8.42 | -6.44 % | $ 239 M | Nasdaq Capital Market | Israel |
 |
Lantheus Holdings
LNTH
|
$ 78.5 | -1.25 % | $ 5.3 B | Nasdaq Global Select Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | Israel |
 |
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | USA |
 |
Medpace Holdings
MEDP
|
$ 453.64 | 0.72 % | $ 13.1 B | Nasdaq Global Select Market,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Mettler-Toledo International
MTD
|
$ 1 198.71 | 2.13 % | $ 24.7 B | NYSE,SPB |  Schweiz |
 |
Celcuity
CELC
|
$ 114.9 | 0.6 % | $ 4.53 B | Nasdaq Global Select Market | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.11 | 0.22 % | $ 1.98 B | Nasdaq Global Select Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 17.4 | 5.33 % | $ 389 M | Nasdaq Global Select Market | USA |
 |
NeoGenomics
NEO
|
$ 8.24 | 4.57 % | $ 1.06 B | Nasdaq Global Select Market,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Natera
NTRA
|
$ 197.68 | 5.23 % | $ 19.5 B | Nasdaq Global Select Market,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.19 | - | $ 826 M | Nasdaq Global Select Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.36 | 2.26 % | $ 408 M | Nasdaq Global Select Market,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.